ABCG2 and breast carcinoma: In vitro, it has been shown that Novobiocin (coumermycin antibiotic) enhances the sensitivity of breast cancer cells to Topotecan by overcoming the breast cancer resistance protein (BCRP)-mediated drug resistance [41].